Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect
暂无分享,去创建一个
R. Storb | B. Sandmaier | D. Maloney | B. Storer | D. Niederwieser | R. Maziarz | E. Maffini | D. Green | L. Anderson
[1] P. Hari,et al. Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[2] H. Deeg,et al. Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] C. Pascutto,et al. Risk of second cancers in Waldenström macroglobulinemia. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] A. LaCasce,et al. Long-term complications of lymphoma and its treatment. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] N. Schmitz,et al. Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] D. Blaise,et al. Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire , 2010, Haematologica.
[7] J. Gribben,et al. The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study , 2008, Hematology.
[8] J. Lipton,et al. Evidence of graft-versus-Waldenstrom's macroglobulinaemia effect after allogeneic stem cell transplantation: a single centre experience , 2007, Bone Marrow Transplantation.
[9] H. Goldschmidt,et al. Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[10] J. Radich,et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. , 2004, Blood.
[11] J. Perrier,et al. Transplantation in Waldenstrom's macroglobulinemia--the French experience. , 2003, Seminars in oncology.
[12] R. Storb,et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissio , 2003, Blood.
[13] H. Deeg,et al. DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment. , 1995, Blood.
[14] H. Deeg,et al. DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors. , 1994, Blood.